For the Record: How Past Experience Enables Future Success
Jakob Lange and Shawn James discuss the value of the experience hidden behind metrics such as completed projects and commercialised devices – the wealth of accumulated process knowledge that enables a company to bring hard-learned lessons forward.
Every pharmaceutical company evaluating the track record of a drug delivery partner starts with roughly the same checklist. Years in business, products launched, devices delivered, manufacturing capacity, number of customers and partnerships, regulatory approvals. These figures are real, and they matter, because they show that a company has repeatedly navigated the technical, regulatory and industrial demands of bringing a combination product to market. They demonstrate that technologies have progressed beyond concepts and prototypes, manufacturing has progressed beyond pilot production, and regulatory strategies have been tested under real commercial conditions. They provide proof.
What they cannot show is what the company actually learned in the process, and that is the harder, more useful question for any leadership team choosing a long-term partner. Every development program builds on and adds to an existing body of knowledge: engineering insights, human factors evidence, regulatory precedent, manufacturing lessons that only become visible once a product is running at commercial scale. When those lessons are captured and disseminated rather than left tied to a single project, experience stops being simply a record of the past and becomes a resource the next customer inherits before their program has even begun.
Ypsomed's four decades in self-injection are a useful test of that idea. More than 80 commercial combination products is a meaningful figure in its own right, but the more telling detail is what sits behind it – thousands of engineering decisions, usability findings, manufacturing refinements and regulatory conversations that continue to shape the platforms in development today. Viewed this way, experience is less a summary of what has already been delivered and more a foundation for what can be built next.